The in depth characterization of the Wnt-receptor and Wnt-ligand expression pattern will allow new insights into the activation of the Wnt-signaling pathway in Barrett’s esophagus and Barrett’s carcinoma, as well as in the pathomechanisms involved in the progression of Barrett’s esophagus. The gene discussed is FZD5; the disease is esophageal adenocarcinoma.